Blood RGS1 expression was increased in NSCLC patients compared with HCs (median [interquartile range]: 2.805 [1.828–4.328] vs. 1.025 [0.718–1.450], P < 0.001, Figure 1). The gene discussed is RGS1; the disease is non-small cell lung carcinoma.